ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of December

December 26, 2014

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

June 24, 2011

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001